Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 17/20 | 0.55 |
| ▸ | NPY1R | P25929 | 10/20 | 0.55 |
| ▸ | NPY5R | Q15761 | 9/20 | 0.55 |
| ▸ | NPY2R | P49146 | 6/20 | 0.55 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31097694 | 1.00 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2RFOLH1 | |
| SCHEMBL31097680 | 1.00 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2RFOLH1 | |
| SCHEMBL31097744 | 1.00 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2RFOLH1 | |
| SCHEMBL30527921 | 0.99 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RFOLH1 | |
| SCHEMBL30527840 | 0.99 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RFOLH1 | |
| SCHEMBL31097711 | 0.99 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RFOLH1 | |
| SCHEMBL31097757 | 0.99 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RFOLH1 | |
| SCHEMBL31097727 | 0.98 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2RFOLH1 | |
| SCHEMBL31097746 | 0.98 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2RFOLH1 | |
| SCHEMBL31097690 | 0.98 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2RFOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118632859-A | Cyclic epitope tag | 生物技术欧洲股份公司 | 2024-09-10 | — | — | CN | claimed |
| CN-122055385-A | Reagents and methods for targeted delivery of immune effector cells | 百欧恩泰欧洲股份公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-119654167-A | Nucleic acid compositions comprising amphiphilic oligoethylene glycol (OEG) conjugated compounds and methods of using such compounds and compositions | 生物技术公司 | 2025-03-18 | — | — | CN | disclosed |
| WO-2025027182-A1 | AGENTS AND METHODS FOR TARGETED DELIVERY TO CELLS | BioNTech SE (DE) | 2025-02-06 | — | — | WO | disclosed |
| EP-4472673-A1 | AGENTS AND METHODS FOR TARGETED DELIVERY OF NUCLEIC ACIDS TO CELLS | BioNTech SE (DE) | 2024-12-11 | — | — | EP | disclosed |
| CN-118973618-A | Agents and methods for targeted delivery of nucleic acids to cells | 生物技术欧洲股份公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118973619-A | Agents and methods for targeted delivery to cells | 生物技术欧洲股份公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118632859-A | Cyclic epitope tag | 生物技术欧洲股份公司 | 2024-09-10 | — | — | CN | disclosed |
| WO-2023148277-A1 | AGENTS AND METHODS FOR TARGETED DELIVERY OF NUCLEIC ACIDS TO CELLS | BioNTech SE (DE) | 2023-08-10 | — | — | WO | disclosed |